Table 2.
Variants | NO of cases 97 |
VEGF expression |
Significance | ||
- | + | ++ | |||
Pathological grade | |||||
Grade I | 6 | 6 | 0 | 0 | NS |
Grade II | 76 | 28 | 22 | 26 | |
Grade III-IV | 15 | 8 | 3 | 4 | |
Tumor size | |||||
2 | 13 | 11 | 0 | 2 | NS |
2-5 | 49 | 16 | 14 | 19 | |
> 5 | 35 | 15 | 11 | 9 | |
Cirrhosis | |||||
With | 53 | 20 | 10 | 23 | NS |
Without | 44 | 22 | 15 | 7 | |
Capsule formation | |||||
With | 18 | 7 | 5 | 6 | NS |
Without | 79 | 35 | 20 | 24 | |
Capsule infiltration | |||||
With | 16 | 4 | 2 | 10 | 0.011a |
Without | 81 | 38 | 23 | 20 | |
Portal vein infiltration | |||||
With | 48 | 14 | 16 | 18 | 0.020a |
Without | 49 | 20 | 9 | 12 | |
Necrosis | |||||
With | 54 | 15 | 17 | 22 | 0.011a |
Without | 43 | 27 | 8 | 8 |
P < 0.05 vs the expression of VEGF was significant in HCC with capsule infiltration, portal vein invasion, and with necrosis. NS, not significant.